Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms.
about
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactionsHLA-B27-associated reactive arthritis: pathogenetic and clinical considerationsAn association between the acute phase response and patterns of antigen induced T cell proliferation in juvenile idiopathic arthritisSelective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumabIntegrin-based therapeutics: biological basis, clinical use and new drugsReview article: anti-adhesion therapies for inflammatory bowel diseasePulmonary-intestinal cross-talk in mucosal inflammatory diseaseAltered migration of gut-derived T lymphocytes after activation with concanavalin A.Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.Two forms of reactive arthritis?Activated memory CD4(+) T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosisAntiadhesion molecule therapy in inflammatory bowel disease.The role of the gut and microbes in the pathogenesis of spondyloarthritis.Absence of peripheral blood T cell responses to "shared epitope' containing peptides in recent onset rheumatoid arthritis.Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma.Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue.Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue: relation of L-selectin and integrin alpha 4 beta 7 to naive and memory phenotypes.Lymphocyte homing to the gut: attraction, adhesion, and commitment.Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways.Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases.Lymphocyte homing and its role in the pathogenesis of IBD.Leukocyte traffic blockade as a therapeutic strategy in inflammatory bowel disease.Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion.Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there.Role of beta7 integrins in intestinal lymphocyte homing and retention.The joint-gut axis in inflammatory bowel diseases.Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.Occult spondyloarthritis in inflammatory bowel disease.Strategies that target leukocyte traffic in inflammatory bowel diseases: recent developmentsEffect of specific antigen stimulation on intraepithelial lymphocyte migration to small intestinal mucosa.Host-microbe interaction in HLA-B27-associated diseases.Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytesIsolation, maturational level, and functional capacity of human colon lamina propria plasma cells.Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies.Rheumatological manifestations in inflammatory bowel disease.Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis.Increased synovial endothelium binding and transendothelial migration of mononuclear cells during Salmonella infection.Review article: bone and joint diseases in inflammatory bowel disease.
P2860
Q24564834-CD7E8AF7-B157-4E28-B977-042A4EEDA0DAQ24625587-4331845F-E633-4852-A9C9-2F68D522ADD0Q24797623-72B31CC0-D9A4-41BB-AFCA-EAA2BA64093EQ26750456-576957F9-DA7D-47A0-94D8-F4E4A1DC60EEQ26773026-0A5423FA-0E5B-4B1D-8E97-67F90CEB14E2Q26999705-530ECDD0-853E-4628-8169-B7DA80EA2635Q27693862-3EB778FA-C6DB-4E77-B014-C4754CAD53C6Q30788616-644D4F39-190D-4314-9FD2-63504B62675AQ33579187-6561BD6C-DC1C-46F6-89C1-F53A78BDF60CQ33782299-2D4CE655-7444-4DF2-A42E-86A53A72C95DQ33817369-46B75491-12DF-4D16-AB3B-9A58B6F334C4Q33876306-97B873BF-35CA-436D-A54B-BCCA8189474DQ34752319-277546B7-EFC3-4866-A3D6-276C6D4A48F5Q34942393-A71F3FCB-EA0B-4252-802D-9A36861BA719Q35547225-587C7B72-1D98-4807-9B15-7E56D604B9E7Q35559655-34818C52-8168-4179-8E84-FBE3833265A1Q35763717-0BC0ACD5-4E02-4DBC-A170-8DABC602C047Q35765315-9654294D-5F87-4989-B4E4-675378B7A6DBQ36209695-4C302F12-9A2E-459E-AF49-F925FE5B4D87Q36327429-8BDD8442-AC26-436B-BAAB-EFA15BF88424Q36405089-4472E66C-5039-4B99-8596-646D533239E1Q36502842-42285E5C-0D78-416B-BCE0-AF5CF4194468Q37130397-DFF4E101-7532-4CA3-97ED-378678D8471FQ37188711-CA52220A-44B5-4F8D-AED5-F6A9012FCBD5Q37366534-E49DE135-18DF-4DA8-B376-72D026FD07CEQ37508056-BFD41B1A-69B0-4D1A-A414-B2740420CAAEQ37622315-B2EE2272-CE91-4C4E-BB17-47F9410F73D1Q37814551-7F5A41C4-C9BB-480E-9F92-CC02530F69D7Q37890928-08261F86-7BD7-4BC9-A5C1-561942AEA275Q38583788-50431E0E-5156-41C0-8981-8B5A5A56DB6DQ38591688-796A829C-2835-4EB2-B1BC-84435EEC0D6BQ40439488-742C082F-782E-48B2-A388-6BBC6438024AQ41488604-F673DA27-279F-49DE-A3DF-070FD648BB6FQ42022690-EB1FA370-216D-4391-AAF7-5A7ABF9CDE75Q42116914-6EE94106-395B-443B-A481-214B9B3DCF2CQ42126037-68A42ED0-4881-42D3-8726-C519FB364AB9Q42406810-5FDE4F5C-156A-47CF-8D61-2205EF9144AAQ47547409-78B2EFA9-7D16-4DDF-98E1-47DC4C543F6EQ47973500-9FAA13C8-8ACF-41B6-9F4F-BE580D2A5EE4Q49172232-B74B7145-077C-4B35-87E3-C813BF236CDD
P2860
Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Dual binding capacity of mucos ...... n of the molecular mechanisms.
@ast
Dual binding capacity of mucos ...... n of the molecular mechanisms.
@en
type
label
Dual binding capacity of mucos ...... n of the molecular mechanisms.
@ast
Dual binding capacity of mucos ...... n of the molecular mechanisms.
@en
prefLabel
Dual binding capacity of mucos ...... n of the molecular mechanisms.
@ast
Dual binding capacity of mucos ...... n of the molecular mechanisms.
@en
P2093
P2860
P356
P1476
Dual binding capacity of mucos ...... n of the molecular mechanisms.
@en
P2093
P2860
P304
P356
10.1084/JEM.181.1.137
P407
P577
1995-01-01T00:00:00Z